A 68-year-old woman with a bone marrow biopsy positive for kappa monotypic plasma cells (approximately 90% total) and flow cytometric analysis showing kappa-restricted plasma cells (approximately 17% of total) had unremarkable serum and urine immunofixation electrophoresis ( Fig. 1 ). Her serum protein electrophoresis was remarkable for hypogammaglobulinemia [IgG 563 mg/dL (reference interval 600-1600 mg/dL), IgA 73 mg/dL (40-375 mg/dL), IgM 17 mg/dL (30-190 mg/dL)]. Serum free light chain (sFLC) results were consistent with the bone marrow biopsy: kappa-sFLC 668 mg/L (3.3-19.4 mg/dL); lambda-sFLC 6.0 mg/dL (5.7-23.3 mg/dL). All serum results were repeated with a second sample.
Fig. 1. Serum immunofixation electrophoresis.
Arrow denotes application point. Lanes labeled according to the antiserum applied (G, anti-IgG; D, anti-IgD; E, anti-IgE; K, total kappa; FK S , free kappa using antisera manufactured by Sebia; FK H , free kappa using antisera manufactured by Helena; L, total lambda; FL S , free lambda using antisera manufactured by Sebia; FL H , free lambda using antisera manufactured by Helena); ϫ2 denotes that the sample was run using 50 L of the sample diluted in 50 L of water.
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techniques, and these assays can therefore be used to aid in diagnosis and monitoring (2 ). 
CASE DESCRIPTION
A 62-year-old female with a history of schizophrenia was found unresponsive after ingesting supratherapeutic amounts of diltiazem and valsartan. At presentation to the emergency department, she was hypotensive and bradycardic. Eight hours later, a blood sample (Fig. 1A) was drawn for chemistry analysis and ultracentrifuged to clarify the turbidity (Fig. 1B) . However, the lab was unable to assay the plasma sample. Multiple samples yielded similar findings. Plasma samples obtained the following day were appropriate for analysis.
QUESTIONS
1. What interfering substances are causing the plasma's strawberry milk appearance? 2. What off-label medication was administered to this patient? 3. What drug(s) may be responsible for causing the abnormal appearance of her plasma?
The answers are below.
ANSWERS
The combination of lipemia and hemolysis caused the plasma's strawberry milk appearance. Lipid emulsion is designed to be infused slowly as part of a total parenteral nutrition regimen. However, this patient received a 120-mL IV bolus of lipid emulsion off-label for its "lipid sink" action against supratherapeutic levels of lipid soluble drugs, such as diltiazem (1 ) . Both lipid emulsion and diltiazem can cause erythrocyte fragility, which may account for the in vivo hemolysis (2-5 ).
